MEDICATION Fake Medicines


Cost EU €10.2 Billion Every Year


A new report from the European Union Intellectual Property Office (EUIPO) has


revealed that fake medicines cost the EU pharmaceutical sector €10.2 billion each year. Tomorrow’s Care finds out more.


A new report from the European Union Intellectual Property Office (EUIPO) shows that 4.4% of legitimate sales of pharmaceuticals are lost each year in the EU due to counterfeiting.


Those lost sales translate into 37,700 jobs directly lost across the pharmaceutical sector in the EU, as legitimate manufacturers and distributors of pharmaceuticals employ fewer people than they would have done in the absence of counterfeiting.


When the knock-on effect of counterfeit pharmaceuticals on other sectors is taken into account, an additional 53,200 jobs are lost elsewhere in the EU economy.


The total yearly loss of government revenue as a result of counterfeit


pharmaceuticals in this sector across the EU-28 in terms of household income taxes, social security contributions and corporate income taxes is estimated at €1.7 billion.


EUIPO’s Executive Director, António Campinos, said: “We know through analysis done by the World Health Organization (WHO) that both generic and innovator medicines are falsified, from cancer treatment products to inexpensive pain treatments. These fakes can be toxic and pose a serious danger to health. Our report shows that they also have a serious impact on the economy and on jobs. Our aim is that our data and evidence-based studies will help policymakers as they devise responses to the challenge of


GERMANY The report estimates that over €1 billion, or 2.9% of the German pharmaceutical


sector’s sales, is lost annually as a result of counterfeiting, with 6,951 direct jobs lost. ITALY


Up to €1.59 billion, or 5% of the Italian pharmaceutical sector’s sales, is lost each year as a result of counterfeiting, the report estimates, with 3,945 direct jobs lost.


FRANCE


The report estimates that over €1 billion, or 3% of the French pharmaceutical sector’s sales, is lost annually as a result of counterfeiting, with 3,667 direct jobs lost.


- 20 - www.tomorrowscare.co.uk combating fake pharmaceuticals.”


The report was released in a joint event organised at the EUIPO with ASGECO, the Spanish General Association of Consumers, as part of its ‘consume original’ campaign.


The report is the ninth in a series of studies undertaken by EUIPO into the economic impact of counterfeiting in industrial sectors in the EU. The series previously looked at the spirits and wine sector; the recorded music sector; the watches and jewellery sector; the handbag and luggage sector; the toys and games sector; the sports goods sector; the clothes, shoes and accessories sector; and the cosmetics and personal care sector.


https://euipo.europa.eu/ohimportal/en


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54